Open access · CC-BY
via OpenAlex
Animal Models of Parkinson’s Disease
Elena A. Konnova, Maria Swanberg
Codon Publications eBooks · 2018 · ▲ 138 citations
Abstract
Parkinson’s disease (PD) is a heterogenous disease with a varying age of onset, symptoms, and rate of progression. This heterogeneity requires the use of a variety of animal models to study different aspects of the disease. Neurotoxin-based approaches include exposure of rodents or non-human primates to 6-OHDA, MPTP, and agrochemicals such as the pesticide rotenone, the herbicide paraquat, and the fungicide maneb. Acute exposure to neurotoxins induces motor deficits and rapid nigro-striatal dopaminergic cell death by disrupting mitochondrial function and/or increasing oxidative stress, while chronic administration of neurotoxins induces progressive models which can include alpha-synuclein (α-synuclein) aggregates. Genetic-based approaches to model Parkinson’s disease include transgenic models and viral vector-mediated models based on genes linked to monogenic Parkinson’s disease, including SNCA, LRRK2, UCH-L1, PRKN, PINK1, and DJ-1, as well as manipulation of dopaminergic transcription factors. SNCA mutations, overexpression, and introduction of α-synuclein preformed fibrils induce toxic protein aggregates and variable nigro-striatal neurodegeneration and motor deficits, depending on the specific model. Species, genetic background of a strain, and environment affect the display of symptoms and neurodegenerative hallmarks of animal models. These models can be combined to study the interplay between genetics and environment and untangle the heterogeneity and mechanisms underlying Parkinson’s disease. In this chapter, we discuss the strengths and limitations of mouse, rat, and non-human primate models of Parkinson’s disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.15586/codonpublications.parkinsonsdisease.2018.ch5
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Konnova, E.A., & Swanberg, M. (2018). Animal Models of Parkinson’s Disease. <em>Codon Publications eBooks</em>. https://doi.org/10.15586/codonpublications.parkinsonsdisease.2018.ch5
Vancouver
Konnova EA, Swanberg M. Animal Models of Parkinson’s Disease. Codon Publications eBooks. 2018. doi:10.15586/codonpublications.parkinsonsdisease.2018.ch5.
BibTeX
@article{elena2018Animal,
title = {Animal Models of Parkinson’s Disease},
author = {Elena A. Konnova and Maria Swanberg},
journal = {Codon Publications eBooks},
year = {2018},
doi = {10.15586/codonpublications.parkinsonsdisease.2018.ch5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurobiology 2013
Open access · OA
α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Current Neuropharmacology 2018
Open access · OA
Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
cIRcle (University of British Columbia) 2017
Preprint · CC-BY
Selective neurodegeneration in Alzheimer's disease and Parkinson's disease
Alzheimer s & Dementia 2017
Citation only
[P1–165]: BLOOD ALPHA‐SYNUCLEIN IN ALZHEIMER'S DISEASE
Parkinson s Disease 2016
Open access · CC-BY
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Journal of Clinical Investigation 2015
Open access · OA